Although modulation of symptoms of obsessive-compulsive disorder (OCD) by serotonergic agents is well established, it is unclear whether an abnormality in the central serotonergic system is involved in its etiology. The serotonin (5-HT) transporter (5-HTT), which is the key modulator of serotonergic neurotransmission, is the target for serotonin reuptake inhibiting drugs (SRIs) that are uniquely effective in the treatment of OCD. In this preliminary study we report an association of a functional polymorphism in the 5-HTT 5Ј regulatory-region and OCD. Seventy-five OCD Caucasian patients and 397 ethnically-matched individuals from a nonpatient control group were genotyped for the 5-HTTLPR. Population-based association analysis revealed that patients with OCD were more likely to carry two copies of the long allele (l) as compared to controls (46.7% vs 32.3%: 2 = 5.19, P = 0.023). This finding replicates a recent family-based study of this polymorphism in OCD, and thus indicates that the 5-HTTLPR may be associated with susceptibility to OCD.
Introduction
Obsessive-compulsive disorder (OCD) is a common psychiatric disorder that affects approximately 1-2% of the US population. 1, 2 The disorder, which is of unknown etiology, is characterized by persistent anxiety-producing intrusive thoughts and inappropriate, ritualistic behavior. 3, 4 Several studies suggest a genetic component in the etiology of OCD. 5, 6 However, little is known about the mode of inheritance of the illness. A number of genes of small effect, as well as environmental factors, may be involved in this apparently etiologically heterogeneous condition. In addition, the selective antiobsessional efficacy of SRIs has led to the hypothesis of a possible serotonergic dysfunction in the pathophysiology of the disease. 7 This view was supported by a recent study showing a within-family association between a functional polymorphism in the upstream regulatory region of the 5-HTT (the 5-HTTlinked polymorphic region or 5-HTTLPR) and OCD. 8 Evidence that the 5-HTT plays a crucial role in OCD comes from the observation that the widely used SRIs are effective in at least half of OCD patients. 4, 9 Thus, the 5-HTT gene, the product of which is the site of initial SRI action, is a plausible candidate that may influence the risk for OCD. Since previous studies failed to reveal any common 5-HTT sequence variations in either neuropsychiatric patients (including OCD patients) or healthy individuals, [10] [11] [12] variation in gene regulatory elements rather than coding variants might influence the susceptibility to OCD. The 5-HTTLPR generally consists of a 44-bp length variation and is located approximately 1 kb upstream from the coding sequence, SLC6A4, on chromosome 17q11.2. 13 The common long (l) and the short (s) variants of 5-HTTLPR direct transcription with different efficiencies, resulting in differential mRNA and protein expression in cultured human serotonergic cell lines, platelets, and post-mortem brain tissue. [14] [15] [16] [17] We examined the influence of the 5-HTTLPR variants on susceptibility to OCD using a case-control design in 75 Caucasian OCD patients and 397 Caucasian controls from a general population sample.
Material and methods

Subjects
All patients in this study were unrelated individuals recruited from the National Institute of Mental Health Adult OCD Outpatient Clinic. Patients were diagnosed by experienced clinicians following interviews which used the Structured Clinical Interview for DSM-III-R (American Psychiatric Association, 1987) 18 as well as the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Seventy-five Caucasian patients who met the diagnostic criteria for OCD (36 women and 39 men) had previously given written informed consent to participate in this NIMH IRB-approved genetic study. The control sample was composed of 397 unrelated healthy volunteers, who were proportionately matched for age, sex and ethnicity, who gave informed consent to participate in an NIMH IRB-approved study of the genetics of normal personality traits.
Genotyping
Genomic DNA was isolated from whole blood using puregene DNA isolation Kits (Gentra Systems, Minneapolis, MN, USA). Genotyping for the 5-HTTLPR was performed as previously described 19 with minor modifications. The 5-HTT regulatory gene region was amplified using a polymerase chain reaction (PCR) with oligonucleotide primers 5Ј-GGCGTTGCCGCTCTGAA TGC (corresponding to 5-HTTLPR nucleotide position from −1416 to −1397) and 5Ј-GAGGGACTGAGCTGGA CAACCAC (from −910 to −889 of the 5-HTTLPR). PCR was performed in a 25-l volume containing approximately 50 ng of genomic template, 0.35 mM of each primer, 150 mM of each dATP, dCTP, and dTTP, 75 mM each of dGTP, and 7Ј-deaza-dGTP, 1.6 units of Taq polymerase (AmpliTaq; Perkin-Elmer, Norwalk, CT, USA), 1.5 mM MgCl 2 , 10 mM Tris-HCl (pH 8.3), 50 mmol L −1 KCl, and 0.001% gelatin. The Taq polymerase was bound to TaqStart antibody (Clontech, Palo Alto, CA, USA) in a molar ratio of 1:28 (Taq polymerase:antibody) before it was added to the reaction mixture to produce a 'hot start' PCR. Samples were processed in a Perkin Elmer GeneAmp PCR system 9600 by two 'touchdown' cycles (95°C for 30 s, 63°C for 30 s, 72°C for 1 min, 95°C for 30 s, 62°C for 30 s, and 72°C for 1 min), followed by 43 cycles with denaturation at 95°C for 30 s, annealing at 61°C for 30 s and extension at 72°C for 1 min. The reaction was ended by incubation at 72°C for 5 min. The PCR products were resolved in a 2% agarose gel containing 0.5 g ml Tables 1 and 2 . Genotype frequencies were distributed according to [14] [15] [16] [17] that the s allele is dominant, we also compared subjects with the l/l genotype to the combined group of l/s plus s/s subjects. Since prior evidence indicated that l/s and s/s genotypes are not distinguishable biochemically or behaviorally-providing an a priori prediction that these groups would also have indistinguishable associations with OCD diagnosis-a Bonferroni correction was unnecessary. This analysis revealed that patients were statistically more likely than controls to carry two copies of the l allele of the polymorphism ( 2 = 5.19; P = 0.023, Table 2 ). The chisquare analysis including all three genotypes indicated a relative risk for OCD in individuals with the l/l genotype of 1.45 (95% confidence interval: 1.12-1.92). Although the allele frequencies of the l variant were somewhat higher in the OCD patients than in the control group (66% vs 59.2%), this was not a significant difference ( 2 = 2.16; P = 0.14).
Discussion
These results indicate that genetic variation in the 5-HTT gene regulatory region may be involved in the pathophysiology of OCD. Our population association study revealed that homozygosity for the higher expressing long allele of the 5-HTTLPR occurs more frequently in subjects with OCD compared to controls.
Population association analysis using the candidate gene approach is a relatively powerful strategy for detecting loci conferring small increases in susceptibility to diseases with complex etiologies. It is hypothesized that most genes affecting the risk of psychiatric illnesses will have such small effects. [20] [21] [22] [23] For example, a recently published case-control study found that a common functional allele of the gene catechol-O-methyltransferase (COMT), which results in a 3-4 fold reduction in enzyme activity, was found to be significantly associated in a recessive manner with susceptibility to OCD. 24 However, the COMT gene contributes only a small portion to the genetic variance, and in this study the significant association was limited to male patients with OCD only, suggesting that a number of susceptibility genes and possibly environmental factors may be involved in OCD.
We found a significant excess of 5-HTTLPR l/l genotypes in the OCD group compared to a general population sample. This promoter variant is associated with higher 5-HTT expression and consequently with greater 5-HT transport capacity. Our data are in accordance with the results of a recently published study which reported preferential transmission of the 5-HTTLPR in OCD patients using a within-family, TDT design; 8 statistical analyses in that study revealed levels of significance similar to those in the present study ( 2 TDT = 4.83; P Ͻ 0.03). Although in another study using a case-control design of 72 patients and 72 unrelated controls, there was a trend towards increased homozygosity (both l/l and s/s) in OCD patients, an association between the 5-HTTLPR and OCD did not reach statistical significance. 25 As has been widely discussed, nonrandom association between a genetic polymorphism and a phenotype can arise because of an influence of the gene on the disorder, or because subpopulations that have different frequencies of the polymorphism also happen to differ in average susceptibility to the disorder, an artifact known as population stratification. However, our data are in agreement with those of a recent study that found a statistically significantly higher occurrence of the l allele in the OCD-group using a within-family design not susceptible to stratification bias. 8 Although the sample size in that study was relatively small, it increases confidence that our association of excess l/l genotypes in OCD is not the result of a sampling artifact. We should note, however, that close linkage with a nearby disease susceptibility locus cannot be excluded at this point, even though positive linkage disequilibrium with a silent VNTR in the second intron of the 5-HTT has been excluded in some earlier studies. 26, 27 Larger studies using within-family designs would provide more definitive information about the relationship of the 5-HTTLPR to OCD. Finally, it is important to emphasize that candidate gene association studies focusing on only one neurotransmitter system are unlikely to be adequate. Linkage and association strategies, as well as analysis of functional haplotypes based on multiple genetic functional and nonfunctional polymorphisms, are needed as complementary approaches to advance the genetics of complex diseases, including neuropsychiatric disorders. In conclusion, our finding indicates that the 5-HTT, one of the main modulators of serotonergic neurotransmission, may be a susceptibility locus for OCD, and, as such, contributes to an emerging body of evidence suggesting that inherited differences in the function of brain 5-HT systems may be etiologically relevant to OCD. 17, 28 
